Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing ...

Nine statements developed, including performing 4 or more versus 3 or fewer needle passes in suspected malignant disease.

Of the about one-third receiving stimulant medication, 71.5% had difficulty filling prescription due to unavailability.

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.

Glucagon-like peptide 1 receptor agonist prescription linked to reduction in risk for suicidal ideation or attempts ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...